Rosetta Genomics Licenses Roche PCR Technology for use in its MicroRNA-Based Diagnostics
News Jan 08, 2008
Rosetta Genomics has announced its wholly owned subsidiary, Rosetta Genomics Inc., has received a license from Roche Molecular Systems to use its PCR technology in Rosetta Genomics' microRNA-based diagnostic tests.
Rosetta Genomics has developed a custom designed, sensitive and specific microRNA detection platform which is based on Roche PCR technology. This proprietary platform allows Rosetta Genomics to identify microRNA biomarkers in several sample types and body fluids, with very high sensitivity and specificity.
"Based on the PCR platform, as well as other proprietary technologies, we are developing a line of highly sensitive microRNA-based products, three of which we expect will launch in 2008," noted Amir Avniel, President and CEO of Rosetta Genomics.
"We have now been granted licenses from both Roche and Nanogen for use of their respective PCR technologies for diagnostic use, and are looking forward to the launch of our first microRNA-based diagnostic tests in 2008".
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE